#$%^&*AU2011101626A420120119.pdf#####ABSTRACT A method is provided for administering to a mammal suffering from, or at risk for, an intraocular neovascular disorder with regular dosing of a therapeutically effective amount of VEGF antagonist, followed by less frequent dosing of a therapeutically 5 effective amount of VEGF antagonist. 3010854_ 1 (GHMatter) P7163AU.0 9-Do-11